Nova BioMedical
Appeals court denies extra fees to BD in test strip row with Abbott
Diabetes: FDA slaps Nova’s glucose test strip recall with a Class I label
After Nova Biomedical issued a voluntary recall letter for its Nova Max test strips and glucose meter kits, the FDA determined that the measure qualified as a Class I recall, a label reserved for issues that pose a threat of significant patient harm.
Diabetes: Nova Biomedical recalls glucose test strips on abnormally high results
Nova Biomedical recalled its Nova Max blood glucose meter test strips after discovering a glitch in which the meters displayed abnormally high results.
The Waltham, Mass.-based medical device company reported that 21 lots were affected by the recall, asking any customer with affected products to immediately stop using the strips.
Massachusetts Life Sciences Center awards $25 million in tax incentives
The Massachusetts Life Science Center has doled out more than $25 million to 25 life science companies who pledged to create new jobs in its latest round of tax incentives,
Premier GPO rolls on with another contract
Hospital purchasing organization Premier Inc. announced a fifth contract this week with news that the Charlotte, N.C.-based GPO would begin providing creatinine hand-held analyzers to certain levels of its membership.
The devices, which are used to assess renal function at bedside, are developed by Nova Biomedical Corp. of Waltham, Mass.
